Abstract
Streptococcus pneumoniae is an important human pathogen that causes severe diseases with high mortality rates. Pneumococcal vaccines are based on capsular polysaccharides, but their production cost is high and their coverage is limited to the serotypes included in the formulation. Thus, the protein vaccines have been investigated as an alternative. Among the studied candidates highlights …